CHÉOS experts support BC study on new COVID-19 drug
A clinical trial for a new COVID-19 treatment developed by Vancouver biotech company AbCellera is about to launch in B.C., thanks to the expertise of CHÉOS staff
Read MoreFebruary 19, 2021
A clinical trial for a new COVID-19 treatment developed by Vancouver biotech company AbCellera is about to launch in B.C., thanks to the expertise of CHÉOS staff
Read More
As Dr. Amy Salmon continues to navigate the long-lasting effects of the virus, she is appreciative of the unique perspective it has brought to her work
Read More
Paramedics are the focus of a new COVID-19 study, led by CHÉOS Scientist Dr. Brian Grunau
Read More
As scientists around the world, including a team at St. Paul's Hospital, are racing to find an effective treatment for COVID-19, CHÉOS project managers are proud to be a small part of this global effort.
Read More
New study led by CHÉOS Scientist Dr. Anne Gadermann will explore the impact COVID-related school disruptions have had on student and teacher wellbeing
Read More
This COVID-19 special edition includes managing chronic kidney disease, facilitating transcatheter aortic valve implantation, and youth mental health and substance use
Read More